Profiel
Dr. Ken A. Selzer, MD, is Founder at INC Research, Inc. and Venture Partner at Finistere Ventures LLC, and at Finistere Partners LLC.
He has extensive years of experience with healthcare service, biotechnology, medical device and pharmaceutical companies.
His business experience has included senior management positions in both an entrepreneurial environment as well as in large companies such as Pharmacia-Pfizer.
Before founding INC Research, Dr. Selzer founded Integrated Healthcare Services, a healthcare service corporation which owned and managed outpatient primary care centers.
IHS was ultimately sold to a major Healthcare Company.
The second company he founded was NEUROPRACTICE, which sold monthly newsletters, written for physicians in the areas of neurology, neurosurgery and pain management fields.
This company was sold to Wolters-Klower, a global publishing company.
He has had hands on experience with in-licensing drugs, development of marketing strategies and new product launches.
He has done advanced training and research, in the neurosciences, at both Vanderbilt Medical Center in Nashville, and the UCSD School of Medicine in San Diego.
He is board certified in both Pain Management and Neurology.
He currently sits on the board of INC Research and is an emeritus board member of the Harvard Business School Alumni Association.
In addition, he is a member of the Scientific Advisory Boards at the Institute for Aging, and Photothera, as well as an active member of WPO.
He has extensive expertise in the areas of developing CNS/Pain drugs and devices.
Dr. Selzer is a graduate of both UCLA School of Medicine and Harvard Business School.
Actieve functies van Ken A. Selzer
| Bedrijven | Functie | Begin |
|---|---|---|
Finistere Partners LLC
Finistere Partners LLC Investment ManagersFinance Finistere Partners focuses on investments that further the global commercialization agricultural biotechnology, agritechnology, industrial biotechnology, nutraceuticals and medical devices companies | Private Equity Investor | 05-04-2011 |
Eerdere bekende functies van Ken A. Selzer
| Bedrijven | Functie | Einde |
|---|---|---|
| FIBROCELL SCIENCE, INC. | Directeur/Bestuurslid | - |
Syneos Health NC LLC
Syneos Health NC LLC Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Oprichter | - |
Finistere Ventures LLC
Finistere Ventures LLC Investment ManagersFinance Finistere Ventures invests in companies located in the United States. The firm focuses on companies operating in broad range of sectors. It provides financing for early stage capital requirements. | Corporate Officer/Principal | - |
Opleiding van Ken A. Selzer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Fibrocell Science, Inc.
Fibrocell Science, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an autologous cell and gene therapy company focused on development of personalized biologics to treat rare skin and connective tissue diseases | Commercial Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syneos Health NC LLC
Syneos Health NC LLC Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Finistere Ventures LLC
Finistere Ventures LLC Investment ManagersFinance Finistere Ventures invests in companies located in the United States. The firm focuses on companies operating in broad range of sectors. It provides financing for early stage capital requirements. | Finance |
Finistere Partners LLC
Finistere Partners LLC Investment ManagersFinance Finistere Partners focuses on investments that further the global commercialization agricultural biotechnology, agritechnology, industrial biotechnology, nutraceuticals and medical devices companies | Finance |
















